Impact of Pharmacist in Cardiology Service
Presence of a Clinical Pharmacist in a Cardiology Department: What Impact on the Management of Diabetic Patients Within Care Pathways? Example of Inpatient Cardiac Patients at GHPSJ
1 other identifier
interventional
44
1 country
1
Brief Summary
The coverage of the diabetes is a multidisciplinary care, with practitioners' implication(hospital and liberal), and other medical and paramedical profession: doctor, pharmacist, male nurse, nutritionist, etc. In fact there is a real importance of link between hospital and general medecine outside. That's why the pharmacist's presence during the hospitalization seems to be a good alternative to make the link between hospital and the outside pharmacist where patient take his treatment. Hospital pharmacis proceed to a treatment conciliation at the entrance and at discharge. By this conciliation the aim of the study is to show and quantify the impact of pharmacist presence on therapeutic target .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 8, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 28, 2017
CompletedFirst Submitted
Initial submission to the registry
June 29, 2017
CompletedFirst Posted
Study publicly available on registry
July 2, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2018
CompletedFebruary 4, 2019
August 1, 2018
2 months
June 29, 2017
February 1, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Measurement of biological test glycosylated haemoglobin evolution between the entrance and discharge
5 days
Study Arms (1)
pharmacist assessment intervention group
OTHERSt Joseph Hospital pharmacist assess every diabetic patient hospitalized in cardiology service in term of antidiabetic treatment during the hospitalization
Interventions
St Joseph Hospital pharmacist assess every diabetic patient hospitalized in cardiology service in term of antidiabetic treatment during the hospitalization
Eligibility Criteria
You may qualify if:
- Diabetes type 2 patient hospitalized in cardiology service
- Hospitalization more than 24 hours
- with insuline or/and oral anti diabetic
You may not qualify if:
- diabètes type 1
- iatrogenic hyperglycaemia
- hospitalization for cardia angiography
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Groupe Hospitalier Paris Saint Joseph
Paris, Île-de-France Region, 75014, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Romain CADOR, MD
GHPSJ
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 29, 2017
First Posted
July 2, 2017
Study Start
March 8, 2017
Primary Completion
April 28, 2017
Study Completion
December 31, 2018
Last Updated
February 4, 2019
Record last verified: 2018-08
Data Sharing
- IPD Sharing
- Will not share